AbbVie (NYSE:ABBV) continues to navigate the challenges of Humira's loss of exclusivity while leveraging its diverse portfolio and robust pipeline to drive future growth. With a gross profit ...

Well before the market open, news broke of those two AbbVie price target increases. They came at the kickoff of the week, when the company was scheduled to post its fourth-quarter earnings (on ...

AbbVie's Rinvoq and Skyrizi could eventually surpass Humira's peak sales. The dividend is well-funded, though an expensive acquisition spree may lead to slower growth. The stock's solid growth ...

Not only did AbbVie’s Skyrizi claim first place in the full-year ranking with nearly $377 million spent on 20 separate ads for the drug, according to iSpot.TV’s analysis, but, with two other ...

In the last year, many AbbVie Inc. (NYSE:ABBV) insiders sold a substantial stake in the company which may have sparked shareholders' attention. When analyzing insider transactions, it is usually ...

Remarkably, against all odds, the band didn’t simply replicate their soft rock formula but instead embraced the experimental—all thanks to the creative vision of Lindsey Buckingham. With Buckingham’s ...

SOMEWHERE TOWARD FREEDOM: Sherman’s March and the Story of America’s Largest Emancipation, by Bennett Parten Commanding an army of some 60,000 men, in late 1864, Maj. Gen. William Tecumseh ...

With a six-week cease-fire now in effect in Gaza, longtime ally Sen. Lindsey Graham (R-S.C.) is urging President-elect Donald Trump to go after Iran with force. The target: Tehran’s nuclear program.

Sen. Lindsey Graham, a key ally of President-elect Donald Trump on the Senate Judiciary Committee, said Sunday that he plans to support Kash Patel, Trump's pick to lead the FBI who has sparked ...